81 related articles for article (PubMed ID: 25231630)
21. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.
Yang Z; Zhang X; Gang H; Li X; Li Z; Wang T; Han J; Luo T; Wen F; Wu X
Biochem Biophys Res Commun; 2007 Jul; 358(3):925-30. PubMed ID: 17512904
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
23. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
24. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans.
Reiter R; Derhaschnig U; Spiel A; Keen P; Cardona F; Mayr F; Jilma B
Thromb Haemost; 2003 Nov; 90(5):898-903. PubMed ID: 14597986
[TBL] [Abstract][Full Text] [Related]
25. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
26. SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin.
Xia R; Jin FY; Lu K; Wan L; Xie M; Xu TP; De W; Wang ZX
Tumour Biol; 2015 Jul; 36(7):5341-51. PubMed ID: 25672609
[TBL] [Abstract][Full Text] [Related]
27. FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L.
Yu S; Yu Y; Zhang W; Yuan W; Zhao N; Li Q; Cui Y; Wang Y; Li W; Sun Y; Liu T
Oncotarget; 2016 Jun; 7(23):34773-84. PubMed ID: 27127880
[TBL] [Abstract][Full Text] [Related]
28. Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.
Wysoczynski M; Liu R; Kucia M; Drukala J; Ratajczak MZ
Mol Cancer Res; 2010 May; 8(5):677-90. PubMed ID: 20442298
[TBL] [Abstract][Full Text] [Related]
29. PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism.
Heider I; Schulze B; Oswald E; Henklein P; Scheele J; Kaufmann R
Oncol Res; 2004; 14(10):475-82. PubMed ID: 15559761
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation.
Tekin C; Aberson HL; Waasdorp C; Hooijer GKJ; de Boer OJ; Dijk F; Bijlsma MF; Spek CA
Cell Oncol (Dordr); 2020 Dec; 43(6):1161-1174. PubMed ID: 32809114
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of stromal interaction molecule 1 may promote epithelial‑mesenchymal transition and indicate poor prognosis in gastric cancer.
Wu G; Li Y; Tan B; Fan L; Zhao Q; Liu Y; Zhang Z
Mol Med Rep; 2017 Jul; 16(1):151-158. PubMed ID: 28534934
[TBL] [Abstract][Full Text] [Related]
32. Thrombin and its protease-activated receptor-1 (PAR1) participate in the endothelial-mesenchymal transdifferentiation process.
Archiniegas E; Neves CY; Candelle D; Cardier JE
DNA Cell Biol; 2004 Dec; 23(12):815-25. PubMed ID: 15684708
[TBL] [Abstract][Full Text] [Related]
33. Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis.
Hirota Y; Osuga Y; Hirata T; Yoshino O; Koga K; Harada M; Morimoto C; Nose E; Yano T; Tsutsumi O; Taketani Y
J Clin Endocrinol Metab; 2005 Jun; 90(6):3673-9. PubMed ID: 15755869
[TBL] [Abstract][Full Text] [Related]
34. A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.
Chay CH; Cooper CR; Gendernalik JD; Dhanasekaran SM; Chinnaiyan AM; Rubin MA; Schmaier AH; Pienta KJ
Urology; 2002 Nov; 60(5):760-5. PubMed ID: 12429291
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin.
Even-Ram SC; Maoz M; Pokroy E; Reich R; Katz BZ; Gutwein P; Altevogt P; Bar-Shavit R
J Biol Chem; 2001 Apr; 276(14):10952-62. PubMed ID: 11278329
[TBL] [Abstract][Full Text] [Related]
36. Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.
Booden MA; Eckert LB; Der CJ; Trejo J
Mol Cell Biol; 2004 Mar; 24(5):1990-9. PubMed ID: 14966279
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of protease-activated receptor 1 via ΔNp63 down-regulation contributes to nodal metastasis in oral squamous cell carcinoma.
Hattori T; Kawano S; Tanaka S; Matsubara R; Sakamoto T; Hashiguchi Y; Kaneko N; Mikami Y; Morioka M; Maruse Y; Kitamura R; Hamada E; Hiwatashi M; Oobu K; Kiyoshima T; Nakamura S
Int J Oral Maxillofac Surg; 2021 Feb; 50(2):163-170. PubMed ID: 32536459
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.
Yang E; Cisowski J; Nguyen N; O'Callaghan K; Xu J; Agarwal A; Kuliopulos A; Covic L
Oncogene; 2016 Mar; 35(12):1529-40. PubMed ID: 26165842
[TBL] [Abstract][Full Text] [Related]
39. PH motifs in PAR1&2 endow breast cancer growth.
Kancharla A; Maoz M; Jaber M; Agranovich D; Peretz T; Grisaru-Granovsky S; Uziely B; Bar-Shavit R
Nat Commun; 2015 Nov; 6():8853. PubMed ID: 26600192
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification.
Xu H; Peng JG; Zhuang YF; Chen JJ; Luo QC; Huang WF; Lin CD; Cai JC
Oncol Rep; 2016 Nov; 36(5):3030-3036. PubMed ID: 27633271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
